Sell-side Review & Stock Update on Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH)

During the past trading session, shares of Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) traded -7.9733%. Covering analysts are predicting the stock to move to $7.2500 within the next year. Depending on the analyst, target price projections may differ widely. This target price is a consensus number based on polled analysts by Thomson Reuters. 

Analysts and investors may use different metrics in order to calculate a price target projection. A very common metric used is the price to earnins ratio of a company. This calculation comes from dividing the current share price by the projected earnings per share. At the time of writing, Tetraphase Pharmaceuticals, Inc has a P/E Ratio of N/A. Investors may also examine a company’s PEG or price to earnings growth ratio. The PEG ratio represents the ratio of the price to earnings to the anticipated future growth rate of the company. A company with a PEG Ratio below one may be seen as undervalued while a PEG Ratio above one may signal that the company is overvalued. A PEG Ratio close to one may be considered to be fair value. Currently, the stock has a PEG Ratio of 0.0000.

Let’s take a quick look at stock performance. Shares are currently trading $0.4098 away from the 50-day moving average of $3.7314 and $0.1973 away from the 200-day moving average of $3.9439. Shares are currently trading -64.9348% away from the 52-week high price of 11.8100 and +33.1576% off the 52-week low of 3.1100. Keeping an eye on the stock price relative to moving averages and yearly highs/lows may help evaluate future stock value.